6657 — Energenesis Biomedical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Energenesis Biomedical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	544	726	485	699	665
Net Total Accounts Receivable
Net Total Receivables	1.62	1.66	1.86	2.26	3.55
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	554	740	503	719	688
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	79.8	89	82.5	77.2	75.8
Net Intangible Assets
Other Long Term Assets
Total Assets	705	886	631	829	781
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	22.8	27.2	24.4	21.3	35.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	32.5	33.4	28.3	24.6	41.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	673	852	603	804	739
Total Liabilities & Shareholders' Equity	705	886	631	829	781
Total Common Shares Outstanding